Midwest Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5M Sell
239,181
-3,047
-1% -$457K 0.42% 62
2026
Q1
$37M Sell
242,228
-7,513
-3% -$1.15M 0.46% 53
2025
Q4
$34.4M Sell
249,741
-2,611
-1% -$342K 0.43% 55
2025
Q3
$32.4M Sell
252,352
-14,541
-5% -$1.77M 0.42% 57
2025
Q2
$32.3M Buy
+266,893
New +$30.1M 0.45% 56

Other funds holding NVS

Midwest Trust's NVS Position: Q2 2026 in Review

Midwest Trust reduced its Novartis (NVS) stake by 1.3% in Q2 2026, selling an estimated $457K and leaving 239,181 shares worth $37.5M. The position accounts for 0.42% of the portfolio, ranked #62.

Midwest Trust first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Midwest Trust held 239,181 shares of Novartis worth $37.5M as of Q2 2026.
  • Midwest Trust sold 3,047 Novartis shares in Q2 2026, an estimated $457K.
  • Novartis made up 0.42% of Midwest Trust's portfolio in Q2 2026, its #62 holding.
  • Midwest Trust first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.